Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc. (ISRG)

Market Open
16 Oct, 01:36 PM
NASDAQ (NGS) NASDAQ (NGS)
$
431. 12
+3.26
+0.7631%
$
149.78B Market Cap
76.32 P/E Ratio
- Div Yield
1,070 Volume
5.59 Eps
$ 427.86
Previous Close
Add Transaction
Day Range
427.58 431.62
Year Range
328.57 603.88
Want to track ISRG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.

Zacks | 25 minutes ago
Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know

Intuitive Surgical, Inc. (ISRG) reached $427.86 at the closing of the latest trading day, reflecting a +1.81% change compared to its last close.

Zacks | 14 hours ago
Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Intuitive Surgical (ISRG) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Intuitive Surgical (ISRG) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks | 23 hours ago
ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?

ISRG Gains Nearly 12% in a Month: Should You Buy, Hold or Sell?

Intuitive Surgical shares have surged nearly 12% in a month ahead of Q3 earnings. Strong da Vinci 5 adoption and Ion growth fuel momentum, but valuation and risks linger.

Zacks | 1 day ago
ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

Intuitive Surgical is targeting GI care with a next-generation robotic endoscope submitted to the FDA, opening a potential growth avenue beyond surgery.

Zacks | 2 days ago
Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Intuitive Surgical (ISRG) Upgraded to Buy: Here's Why

Intuitive Surgical (ISRG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 2 days ago
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 2 days ago
Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to Consider

Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $423.96, signifying a +2.06% move from its prior day's close.

Zacks | 6 days ago
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?

Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 1 week ago
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know

Intuitive Surgical, Inc. (ISRG) reached $414.52 at the closing of the latest trading day, reflecting a +2.41% change compared to its last close.

Zacks | 1 week ago
Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?

Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?

Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.

Zacks | 1 week ago
Intuitive Surgical: The Multiple Fell, The Story Didn't

Intuitive Surgical: The Multiple Fell, The Story Didn't

Intuitive Surgical remains a wide-moat leader in robotic surgery with strong secular tailwinds and high recurring revenue potential. ISRG's installed base and utilization rates offer significant runway for growth, supported by product innovation and expansion into new markets. Despite a compression in valuation multiples, ISRG's forward P/E remains attractive given its historical premium and robust growth prospects.

Seekingalpha | 1 week ago
Loading...
Load More